Company News

Share this article:
Heritage Pharmaceuticals and Ipca Laboratories have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the US prescription drug market. Under the agreement, Ipca shall develop and register selected products for US ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch. Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its US label in 2006. Ipca Laboratories, based in Mumbai, India, is engaged in the manufacturing and marketing of a range of pharmaceuticals with a focus on international business.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.

India's Marck gets FDA Warning Letter

Inspectors of Marck Biosciences found an array of problems during a October-November 2013 inspection, including mold near a sterile area that was so bad "the room had 'partially caved in.'"

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.